Zitong Financial APP learned that Credit Suisse issued a research report that downgraded the shamrock-B (02197) rating from "outperform" to "neutral", but raised its profit forecast for the year after next year by 49% to 102%, with the target price raised from HK $3.40 to HK $4.80.

The company's order for 64 million doses of COVID-19 vaccine candidate "SCB-2019" from Gavi (Global Alliance for Vaccines and Immunization) will be carried out within four years at the discretion of Gavi, indicating reduced demand for Gavi, the report said. In addition, Novavax also terminated its vaccine supply agreement with Gavi and said Gavi failed to purchase the promised vaccine. Therefore, the bank believes that the demand for COVID-19 vaccine of clover mainly comes from the Chinese market.